M. Leboyer, I. Soreca, J. Scott, M. Frye, C. Henry et al., Can bipolar disorder be viewed as a multi-system inflammatory disease? Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research, J Affect Disord Circulation Trends Pharmacol Sci, vol.1414, issue.30, pp.1-10, 1997.

P. Stolk, P. C. Souverein, I. Wilting, H. G. Leufkens, D. F. Klein et al., Is aspirin useful in patients on lithium? A pharmacoepidemiological study related to bipolar disorder, Comorbidities and mortality in bipolar disorder: a Swedish national cohort study, pp.9-14, 2010.
DOI : 10.1016/j.plefa.2009.10.007

]. K. Munkholm, M. Vinberg, L. Kessing, D. W. Gilroy, R. Medeiros et al., Cytokines in bipolar disorder: a systematic review and meta-analysis The role of aspirin-triggered lipoxins in the mechanism of action of aspirin Aspirin-triggered lipoxin a4 stimulates alternative activation of microglia and reduces Alzheimer disease-like pathology in mice, Mukhtar and M.U. Rehman, Aspirin and immune system, pp.16-27, 2005.

B. N. Cronstein, M. C. Montesinos, and G. Weissmann, Sites of action for future therapy: an adenosine-dependent mechanism by which aspirin retains its antiinflammatory activity in cyclooxygenase-2 and NF??B knockout mice, Osteoarthritis and Cartilage, vol.7, issue.4, pp.361-363, 1999.
DOI : 10.1053/joca.1998.0236

D. Taubert, R. Berkels, N. Grosser, H. Schroder, D. Grundemann et al., Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action, British Journal of Pharmacology, vol.231, issue.1, pp.159-165, 2004.
DOI : 10.1038/sj.bjp.0705907

M. Grilli, M. Pizzi, M. Memo, and P. Spano, Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-kappa B Activation, Science, vol.274, issue.5291, pp.1383-1385, 1996.
DOI : 10.1126/science.274.5291.1383

M. Basselin, E. Ramadan, M. Chen, and S. I. Rapoport, Retraction Note to: Anti-Inflammatory Effects of Chronic Aspirin on Brain Arachidonic Acid Metabolites, Neurochemical Research, vol.40, issue.5, pp.139-145, 2011.
DOI : 10.1007/s11064-015-1583-4

X. R. Gao, C. M. Adhikari, L. Y. Peng, X. G. Guo, Y. S. Zhai et al., Efficacy of different doses of aspirin in decreasing blood levels of inflammatory markers in patients with cardiovascular metabolic syndrome, Journal of Pharmacy and Pharmacology, vol.163, issue.11, pp.61-1505, 2009.
DOI : 10.1211/jpp.61.11.0010